Who owns Galectin Therapeutics Inc.?
Institutional ownership of GALT from SEC Form 13F filings across 80 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
80
13F holders
$64.9M
value, 2026 filers
21.8%
of shares outstanding (14.4M sh)
18
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of GALT's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 3.0M | $13.9M | 0.0% | 4.5% | +273.9% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 2.2M | $10.1M | 0.0% | 3.3% | -44.9% |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 1.3M | $6.1M | 0.0% | 2% | +113.5% |
| 4 | OSAIC HOLDINGS, INC. | 1.2M | $5.6M | 0.0% | 1.8% | +7.2% |
| 5 | MARSHALL WACE, LLP | 831,010 | $3.9M | 0.0% | 1.3% | -31.9% |
| 6 | Wealthspire Advisors, LLC | 721,788 | $3.3M | 0.0% | 1.1% | 0.0% |
| 7 | COMMONWEALTH EQUITY SERVICES, LLC | 407,113 | $1.9M | 0.0% | 0.6% | +10.9% |
| 8 | NORTHERN TRUST CORP | 386,545 | $1.8M | 0.0% | 0.6% | +196.3% |
| 9 | VANGUARD FIDUCIARY TRUST CO | 366,476 | $1.7M | 0.0% | 0.6% | +20.5% |
| 10 | VANGUARD PORTFOLIO MANAGEMENT LLCNEW | 327,766 | $1.5M | 0.0% | 0.5% | new |
| 11 | TWO SIGMA INVESTMENTS, LP | 318,245 | $1.5M | 0.0% | 0.5% | -31.9% |
| 12 | LPL Financial LLC | 285,380 | $1.3M | 0.0% | 0.4% | +6.8% |
| 13 | Cambridge Investment Research Advisors, Inc. | 261,296 | $1,212 | 0.0% | 0.4% | +103.1% |
| 14 | Sovran Advisors, LLC | 257,997 | $874,610 | 0.1% | 0.4% | +0.1% |
| 15 | UBS Group AG | 219,319 | $1.0M | 0.0% | 0.3% | +22.0% |
| 16 | CITADEL ADVISORS LLC | 198,701 | $921,973 | 0.0% | 0.3% | -31.6% |
| 17 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 177,197 | $822,194 | 0.0% | 0.3% | -68.1% |
| 18 | NATIONAL BANK OF CANADA /FI/NEW | 167,900 | $779,056 | 0.0% | 0.3% | new |
| 19 | BLAIR WILLIAM & CO/IL | 149,283 | $692,673 | 0.0% | 0.2% | 0.0% |
| 20 | Sixth Street Partners Management Company, L.P.NEW | 116,424 | $540,207 | 0.1% | 0.2% | new |
| 21 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 116,424 | $540,207 | 0.0% | 0.2% | +288.0% |
| 22 | Bank of New York Mellon CorpNEW | 105,742 | $490,644 | 0.0% | 0.2% | new |
| 23 | HighTower Advisors, LLC | 94,125 | $436,740 | 0.0% | 0.1% | +0.8% |
| 24 | MORGAN STANLEY | 93,475 | $433,724 | 0.0% | 0.1% | -10.5% |
| 25 | GOLDMAN SACHS GROUP INC | 74,554 | $345,931 | 0.0% | 0.1% | -59.6% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.